Highlights Twist Bioscience Corporation

Equities

TWST

US90184D1000

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-22 pm EDT			5-day change	1st Jan Change
43.09 ^USD	-2.16%		-10.90%	+16.90%

May. 03	Sector Update: Health Care Stocks Mixed Late Afternoon	MT
May. 03	Sector Update: Health Care Stocks Mixed in Afternoon Trading	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Mixed Late Afternoon	May. 03	MT
Sector Update: Health Care Stocks Mixed in Afternoon Trading	May. 03	MT
Twist Bioscience Shares Jump After Fiscal Q2 Beat, Fiscal 2024 Revenue Guidance Raised	May. 03	MT
Earnings Flash (TWST) TWIST BIOSCIENCE CORPORATION Posts Q2 Revenue $75.3M, vs. Street Est of $70.8M	May. 02	MT
Twist Bioscience Corporation Revises Earnings Guidance for the Fiscal Year 2024	May. 02	CI
Twist Bioscience Corporation Provides Earnings Guidance for the Third Quarter and Fourth Quarter of Fiscal Year 2024	May. 02	CI
Twist Bioscience Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	May. 02	CI
Twist Bioscience Corporation Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations	Mar. 28	CI
Twist Bioscience Corporation Launches IVDR-Compliant Precision Dx Products for Whole Exome Sequencing	Mar. 05	CI
Twist Bioscience Announces Partnership With Element Biosciences, Launches Liquid Biopsy Kit	Feb. 06	MT
Twist Bioscience Corporation and Element Biosciences, Inc. Announce Collaboration to Develop Twist for Element, Exome 2.0 Plus Comprehensive Exome Spike-In Workflow for Element?s AVITI System	Feb. 06	CI
Twist Bioscience Corporation Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications	Feb. 06	CI
Twist Bioscience Corporation Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT	Feb. 05	CI
Twist Bioscience's Fiscal Q1 Net Loss Widens, Revenue Rises; Fiscal 2024 Revenue Guidance Lifted	Feb. 02	MT
Earnings Flash (TWST) TWIST BIOSCIENCE CORPORATION Reports Q1 Revenue $71.5M, vs. Street Est of $67.6M	Feb. 02	MT
Twist Bioscience Corporation Provides Revenue Guidance for the Second Quarter of Fiscal Year 2024	Feb. 02	CI
Twist Bioscience Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 02	CI
Twist Bioscience Corporation Updates Earnings Guidance for the Full Fiscal Year 2024	Feb. 02	CI
North American Morning Briefing : Jobs Report Tops -2-	Feb. 02	DJ
Twist Bioscience Corporation Expands Express Genes Rapid Synthesis Service	Jan. 24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Twist Bioscience Corporation

Equities

TWST

US90184D1000

Highlights

Filters